Archana Chidambaram

MD, PhD

Credentials

Positions

Roswell Park Comprehensive Cancer Center
  • Hematology-Oncology Fellow (Class of 2017)

Background

Education and Training:

  • Seth G. S. Medical College, India
  • Virginia Commonwealth University, Richmond, VA

Residency:

  • Internal Medicine, Cooper University Hospital, Camden, NJ

Publications

Wilms tumor 1 gene, CD97, and the emerging biogenetic profile of glioblastoma. Somasundaram A, Ardanowski N, Opalak CF, Fillmore HL, Chidambaram A, Broaddus WC. Neurosurg Focus. 2014 Dec;37(6):E14.

Chidambaram A, Rodriguez D, Khan S, Gower L.Biomimetic Randall's plaque as an in vitro model system for studying the role of acidic biopolymers in idiopathic stone formation. Urolithiasis. 2015 Jan;43 Suppl 1:77-92.

Chidambaram A, Fillmore HL, Van Meter TE, Dumur CI, Broaddus WC. Novel report of expression and function of CD97 in malignant gliomas: correlation with Wilms tumor 1 expression and glioma cell invasiveness. J Neurosurg. 2012 Apr;116(4):843-53.

Chen MY, Clark AJ, Chan DC, Ware JL, Holt SE, Chidambaram A, Fillmore HL, Broaddus WC. Wilms' tumor 1 silencing decreases the viability and chemoresistance of glioblastoma cells in vitro: a potential role for IGF-1R de-repression. J Neurooncol. 2011 May;103(1):87-102.

Chidambaram A, Fillmore HL, Van Meter TE, Dumur CI, Broaddus WC. Novel report of expression and function of CD97 in malignant gliomas: correlation with Wilms tumor 1 expression and glioma invasiveness. J Neurosurg 116(4): 843-53, 2012.

Chen MY, Clark AJ, Chan DC, Ware JL, Holt SE, Chidambaram A, Fillmore HL, Broaddus WC. J Neurooncol 103(1): 87-102, 2011.